Cold Chain Global Forum West Coast

February 26 - 27, 2020 | San Diego, CA

Main Conference Day Two: Thursday, 27 Feb 2020

8:00 am - 9:00 am Registration & Welcome Coffee

Analyzing New Trends in Temperature Controlled Logistics

9:00 am - 9:40 am Establishing a Patient-Centric, Cost Effective and Secure Supply Chain for Biologics, Cell and Gene Therapy Products

Chris Wallace - Senior Director, International Supply Chain Operations, Genzyme Europe
In this opening keynote, Chris will provide attendees with an illuminating perspective on how to overcome key challenges when it comes to the transportation and supply chain of the fastest growing trend in the pharma world - biologics. Drawing from international experience, this session will provide attendees with best practices from a large pharma’s perspective.

img

Chris Wallace

Senior Director, International Supply Chain Operations
Genzyme Europe

  • Taking more ownership of the product- Moving beyond a transactional, volume-based approach to understanding your customers’ needs
  • Dealing with increased pressure to be far more productive and cost-efficient
  • Moving from a 3PL to 4PL model- Can we really harmonize a fragmented system?
  • Customizing bespoke solutions for specialty logistics and distribution opportunities including: newer types of biologics, oncology products and lucrative drugs approved for rare diseases
  • Dealing with the elephant in the room: Is Amazon going to complement or compete with the current supply chain framework?
img

Hristo Marinov Petkov

Global Head of Pharmaceuticals
Maersk

img

Chris Wallace

Senior Director, International Supply Chain Operations
Genzyme Europe

img

Kevin Hickman

Senior Manager, Supply Chain Distribution
Gilead Sciences, Inc.

10:20 am - 11:00 am Morning Coffee Break and Cold Chain Mentoring Program Continues

Spent Day 1 with your Cold Chain Mentor and found the coaching sessions valuable? Continue your conversations over morning coffee!

Cold Chain Risk Management and Validation Best Practices

11:00 am - 11:40 am PANEL DISCUSSION: Analyzing Best Practices and Benchmarks in Shipping Qualification and Packaging Validation

Eric Barnitz - Sr. Packaging Engineer, Kite Pharma
John DeTurk - Senior Manager, Distribution and Shipping Validation / Logistics, Seattle Genetics
• Quick wins and tips to accelerate the validation process and source for the right shippers
• Lessons learnt and best practice in shipping qualification and packaging validation
• Reviewing next steps forward

Eric Barnitz

Sr. Packaging Engineer
Kite Pharma

John DeTurk

Senior Manager, Distribution and Shipping Validation / Logistics
Seattle Genetics

11:40 am - 12:20 pm Revisiting Sea Freight as a Viable and Cost Effective Shipping Lane: Data Findings and Update from the Poseidon Project

Alan Kennedy - Director, Poseidon Project
This session will provide attendees with a comprehensive overview of the Poseidon Project and the most up-to-date data findings on the Sea Freight project that key stakeholders in the Pharma industry are collaborating on. The session will cover various aspects of sea freight as a viable transportation lane, including regulatory compliance, quality assurance, insurance and technological innovations. The aim of this session is to provide attendees with a firm understanding of the benefits and viability of sea freight.

img

Alan Kennedy

Director
Poseidon Project

12:20 pm - 1:20 pm Lunch and Networking Break

1:20 pm - 2:20 pm Risk Management And Overcoming Challenges In Sea Freight - Focus On Quality, Regulatory Compliance, Time-Sensitivity And Insurance

Alan Kennedy - Director, Poseidon Project
img

Alan Kennedy

Director
Poseidon Project

Effective Cold Chain Quality and Delivery Strategies

  • Ocean freight visibility - technologies that keep you in charge
  • Exploding the Myths – the truth about pharma ocean-freight risks
  • Making sea freight work – it’s all in the planning
  • Ocean freight LCL –sending smaller shipments safely by sea to Asia
Interactive Roundtables
  1. Sustainability - Huge changes will take place over the next few years as mankind adapts to a low-carbon future. What role do you expect ocean freight to play in this?
  2. Barriers to using ocean freight - What are the principal barriers to the adoption of ocean freight for high value pharma and what can be done to overcome these?
Sea Freight Focus Day Leader:
img

Alan Kennedy

Director
Poseidon Project

Kelvin Tan

Deputy CEO
Halterm Container Terminal, a PSA Company

img

Hristo Marinov Petkov

Global Head of Pharmaceuticals
Maersk

3:20 pm - 3:20 pm Closing Remarks from Conference Chairman and End of Conference